TIP UPJŠ — Technologický a inovačný park metabolitemarket.com

B2 Proteins & Enzymes · Enzyme engineering · Directed evolution

Haloalkane Dehalogenase Engineering Platform

Carbon–halogen bond cleavage for remediation and industrial process chemistry. Directed evolution, ribosome display and catalytic optimisation applied to your substrate — relevant wherever a process generates or handles halogenated streams.

Evidence
Capability & method data under NDA
Stage
Pilot-ready · licensing open
Indicative
€ 15 000 – 120 000negotiable by scope and application

What the platform does

Haloalkane dehalogenases cleave carbon–halogen bonds. Wild-type enzymes rarely have the activity, stability or substrate range an industrial process needs, so the platform applies directed evolution and display-based selection to move the enzyme towards your substrate and your conditions.

Who this is for

Processes that generate or handle halogenated streams, remediation programmes with a defined contaminant, and green-chemistry substitutions where a biocatalytic step could replace a harsher chemical one. The first question is always whether your specific substrate is tractable — which is a feasibility scan, not a full campaign.

Applications

  • Biocatalysis on halogenated substrates
  • Bioremediation of contaminated streams
  • Green chemistry process substitution
  • Enzyme variant libraries for a target reaction

Methods available

  • Directed evolution campaigns
  • Ribosome display selection
  • Catalytic efficiency optimisation
  • Stability and condition profiling

Specification

Technology typeEnzyme engineering / directed evolution
Research groupCIB — Centre for Interdisciplinary Biosciences
Evidence statusPilot-ready capability; method and validation data under NDA
Typical pilotFeasibility scan first, then a multi-month programme
DeliverablesEngineered variants, activity and stability data, method report
EngagementFeasibility scan · programme · licensing · co-development
Indicative price€ 15 000 – 120 000, negotiable by scope and application

What happens next

  1. Book a call or send an inquiry. Tell us the target, the application and the timeline.
  2. We answer within three working days — including when the answer is that we cannot help.
  3. NDA before disclosure, if you need one. Tick the box on the form.
  4. Feasibility scan or pilot proposal with a defined scope, deliverable and price.

Book a 30-minute discovery call Send an inquiry

Common questions

How does an engagement start?
With a free 30-minute discovery call. We establish whether there is a fit and what the right next step is. Nothing is committed at that point.
Can we sign an NDA before we describe our project?
Yes. Tick the NDA box on the inquiry form and we arrange it before any disclosure.
Are the prices on this site binding?
No. They are indicative ranges so that you can size a project before contacting us. Final terms are negotiated per scope.
How quickly do you reply?
Every inquiry is acknowledged within one working day and answered by the responsible group leader within three.
What happens if you cannot help?
We say so, early, and where we can we point you to someone who can. A negative feasibility answer delivered quickly is a useful result.

Related in Proteins & Enzymes

B1Flagship platform

Protein engineering · Fibrinolytic variants

Staphylokinase Variant Screening Platform

Rank hundreds of variants without purifying each one. A cell-free expression platform scores staphylokinase variants by activity directly from unpurified reactions — built for engineering campaigns where variant numbers make conventional screening impractical.

  • Cell-free screening
  • High-throughput ranking
  • Protein engineering
Evidence
Publication reported 2026 · data package under NDA
Stage
Pilot-ready · co-development open
Indicative
€ 12 000 – 60 000co-development quoted individually
B3

Protein biophysics · Formulation support

Protein Stability & Formulation Platform

Know before you formulate. DSC, fluorescence probes and dynamic light scattering map thermodynamic and kinetic stability; buffer, salt and pH screening and aggregation risk profiling are run on your protein rather than on a generic prediction.

  • Thermal stability
  • Aggregation risk
  • Buffer optimisation
Evidence
Method portfolio · report under NDA
Stage
Pilot-ready
Indicative
€ 8 000 – 50 000negotiable by scope and application
B4

Protease activity · Condition optimisation

HRV 3C Protease Optimisation Platform

Kosmotropic anions increase HRV 3C protease rigidity, stability and catalytic efficiency — a published finding with direct workflow consequences. If your production depends on a cleavage step, this tells you which conditions maximise yield and enzyme lifetime.

  • Protease workflow
  • Salt screening
  • Enzyme stability
Evidence
Peer-reviewed 2022 (Biophys. Chem.)
Stage
Pilot-ready
Indicative
€ 6 000 – 35 000negotiable by scope and application

Tell us what you are trying to achieve.

A free 30-minute call establishes whether there is a fit and what the right next step is. Every inquiry is acknowledged within one working day and answered by the responsible group leader within three.